NSE - Delayed Quote INR
Divi's Laboratories Limited (DIVISLAB.NS)
6,012.50
-203.00
(-3.27%)
At close: April 25 at 3:30:00 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
12,610,000
24,590,000
19,118,000
19,469,300
Investing Cash Flow
--
-2,690,000
-27,070,000
-21,949,200
751,300
Financing Cash Flow
--
-7,990,000
-7,970,000
-5,324,400
-348,900
End Cash Position
--
3,630,000
1,700,000
12,147,600
20,303,200
Capital Expenditure
--
-10,030,000
-4,730,000
-7,132,000
-9,101,900
Repayment of Debt
--
--
--
--
-332,800
Free Cash Flow
--
2,580,000
19,860,000
11,986,000
10,367,400
3/31/2021 - 3/12/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LAURUSLABS.NS Laurus Labs Limited
625.65
-3.08%
SUNPHARMA.NS Sun Pharmaceutical Industries Limited
1,787.40
-0.91%
NATCOPHARM.NS NATCO Pharma Limited
889.25
-1.51%
DRREDDY.NS Dr. Reddy's Laboratories Limited
1,174.80
-2.14%
CIPLA.NS Cipla Limited
1,525.90
-1.66%
AUROPHARMA.NS Aurobindo Pharma Limited
1,220.10
-3.00%
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,360.70
-4.24%
ABBOTINDIA.NS Abbott India Limited
29,705.00
-1.18%
LUPIN.NS Lupin Limited
2,019.60
-4.02%
WOCKPHARMA.NS Wockhardt Limited
1,397.60
-4.61%